Craig Venter says that he has been "successful in is finding alternate ways to fund research," in the New York Times. A venture capitalist friend, Alan Walton, adds that "Craig is just a hopeless businessman." Venter began Synthetic Genomics as a way to fund his research in synthetic biology, and his work there has garnered attention — Venter notes he heard from the president and the pope on the same day after announcing the activation of a synthetic genome.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.